Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis
Shuchi Anand, Maria E. Montez‐Rath, Jialin Han, Pablo García, LinaCel Cadden, Patti Hunsader, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A. Block, Scott D. Boyd, Julie Parsonnet, Glenn M. Chertow
Abstract
Data from hepatitis B[1][1] and influenza vaccination[2][2] studies indicate blunted and foreshortened response to immunization in patients receiving dialysis, raising the worrisome possibility that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine may also yield lower
Topics & Concepts
MedicineVaccinationCoronavirus disease 2019 (COVID-19)DialysisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunizationVirologyAntibody responseAntibodyPandemicImmunologyInternal medicineIntensive care medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHepatitis B Virus Studies